temozolomide

FDA Drug Profile — TEMOZOLOMIDE, temozolomide

temozolomide is listed in the FDA National Drug Code directory with 16 NDC codes, marketed under brand names including TEMOZOLOMIDE, temozolomide. Available dosage forms: capsule, injection, powder, lyophilized, for solution, powder.

Drug details

Generic Name
temozolomide
Brand Names
TEMOZOLOMIDE, temozolomide
Application Number
ANDA206309
Sponsor
Rising Pharma Holdings, Inc.
NDC Codes
16
Dosage Forms
CAPSULE, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, POWDER
Routes
ORAL
Active Ingredients
TEMOZOLOMIDE

Indications and Usage

1. INDICATIONS AND USAGE TEMOZOLOMIDE Capsules are an alkylating drug indicated for the treatment of adult patients with: Newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. ( 1.1 ) Anaplastic astrocytoma ( 1.2 ) Adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma. ( 1.2 ) Treatment of adults with refractory anaplastic astrocytoma. ( 1.2 ) 1.1 Newly Diagnosed Glioblastoma TEMOZOLOMIDE Capsules is indicated for the treatment of adults with newly diagnosed glioblastoma, concomitantly with radiotherapy and then as maintenance treatment. 1.2 Anaplastic Astrocytoma TEMOZOLOMIDE Capsules is indicated for the: adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma; treatment of adults with refractory anaplastic astrocytoma.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.